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5-hydroxyindolylacetic acid (5-HIAA), a major serotonin cata-
bolite, is eliminated in urine. In carcinoid tumours,95 ofwhich
occur in the small intestine, large quantities of serotonin are
secreted by the entero-chromaffin cells of Kultchizky-Masson.
Early detection of these tumours is essential, since unless they
are surgically treated in the initial stages then their prognosis is
serious. Early detection can be ensured by measuring blood
serotonin and urinary 5-HIAA [1].
Systematic determination of urinary 5-HIAA needs a quick,
reliable and automated technique. Neither the e-nitrosonaphtol
colorimetric method [2] nor spectrofluorometry after ethyl
acetate extraction [3] are suitable: the first lacks specificity and
the second is a lengthy and tricky process. Both these methods
are manual. Low-pressure chromatography techniques are
time-consuming (5-HIAA retention time is over 30min.) and
they are either insufficiently sensitive or unreliable [4,5, 6].
Reverse-phase separation chromatography also lacks sensitivity
and specificity [7-1, unless it is preceded by manual extraction
which, again, is often time-consuming and reduces the
technique’s precision. High-performance liquid chromatog-
raphy (HPLC), however, allows fast separation [8].
The method the authors propose rests on the following
principle: 5-HIAA is separated from the other metabolites by
anion exchange HPLC at pH2.30, this permits fast, efficient
separation. Continuous-flow spectrofluorometric detection is
carried out atpH 7"0, at excitation and fluorescence wavelengths
of 301 and 338nm respectively. Chromatography and detection
are continuously coupled, in accordance with a process which
was worked out in the authors’ laboratory I-9, 10] and permits
optimalization of 5-HIAA pH readings. The use of an auto-
mated injector increases precision and allows large numbers of
samples to be handled.
Materials and methods
Apparatus
(1) High-performance liquid chromatograph Chromatem
38 (Touzart Matignon).
(2) Column: Whatman Partisil SAX 10 #m, 250 x 4"7mm
(i.d.) and precolumn 150 x 4"7 mm.
(3) Peristaltic-pump, fluorometer and recorder (Technicon
Autoanalyzer II).
(4) Automated sampler and injector (Micromeritics 725
Coultronics).
Reagents and standard
The mobile phase (R 1) consists ofa buffer solution (NH4H2PO4,
5 10- mol/l) adjusted to pH 2"30 with concentrated H3PO,.
R2 is a phosphate buffer solution at pH7"0, 0.1mol/1
(Na2HPO4, 2H20 8.7g/1 and KH2PO, 5.6g/1). R1 and R2 keep
for three months at +4C. R3 is sulphosalicyclic acid solution
(500 g/l) in distilled water. The 250 #mol/1 5-HIAA standard is
prepared with 0.01 mol/l HC1 from a stock solution containing
2.5 mmol/1 5-HIAA in 0.01 mol/1 HC1. The standard keeps two
weeks and the stock solution keeps three months, both at +4C
in brown flasks. The internal standard is a 2mmol/1 N-
acetyltryptophan (NAT) solution in 0.1 mmol/1HC1. It keeps for
three months at +4C in dark bottles.
Preparation of urine samples and determinations
procedures
Urine was collected over a 24h period in 5 ml of hydrochloric
acid (10mol/1). During the day before collection, subjects were
asked to avoid some foods, especially bananas and grapefruit,
and drugs like reserpine, fluorouracile, heparin, isoniazide,
methyldopa, IMAO, corticotrophin and metamphetamine,
which are liable to change the in vivo urinary concentrations of
5-HIAA.
5 ml urine was acidified by adding 50 #1 of sulphosalicyclic
acid solution (R3). The preparation was then vortex-stirred for
15 s, centrifuged when necessary and filtered.
Determinations were made as follows: for standardization,
each subject’s urine was submitted to double overloading with
known amounts of 5-HIAA in the presence of an internal
standard (NAT). An external standard was used for each series of
determinations, for the sole purpose ofverifying the fluorescence
yield of overloading. When an automatic injector is available,
the amounts indicated in table can be introduced directly into
the sampling vials. 50#1 of each sample was automatically
injected every 7 min.
A diagram ofthe apparatus used is shown in figure 1; the flow
rate was 1.50 ml/min. An example ofa urinary chromatogram is
presented in figure 2.
Calculation of urine concentrations
The heights of the peaks corresponding to 5-HIAA were
measured (A for U [urine]; B for U+25#mol/1; C for
U+ 50#mol/1). The peaks corresponding to NAT were also
measured (a for U; b forU+ 25 #mol/1; and c forU+ 50 pmol/1).
S is the corrected height for an average overload of5-HIAA
equivalent to 25 #mol/1 and was calculated as follows:
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The final urine concentration was:
25 A
C #mol/1=--
x #mol/1,
C #mol/24 h C #mol/1 x urinary flow 1/24 h,
C #mol/l C #mol/mmol of creatinine C creatinine mmol/l"
Results and discussion
Choice of experimental conditions
pH and mobile phase molarity were studied within limits
compatible with the stationary phase. The pH was varied from
1"50 to 7.00, and the molarity from 10
.4 mol/1 to mo.1/l.
Optimal conditions were at pH2"30 and a molarity of
5 x 10-3 mol/l. Under these conditions 5-HIAA was well sep-
Automated
injector
arated from its metabolites (tryptophan or Trp, hydroxy-5-
tryptamine or 5-HT and hydroxy-5-tryptophan or 5-HTP) (see
figure 2).
Table 1. Sampling conditions for the automatic injector.
External U U+ U+
standard 25/mol/1 50 #mol/1
NAT (2 mmol/l) 100/21
(internal standard)
5-HIAA (250 #mol/1) 50 #1
Mobile phase 550 #1
Acidified urine
100 #1 100 #1 100/21
50 #1 100 #1
100 #1 50 #1 500 #1
500 #1 500 #1 500/d
Vortex-stir for 15
SAX I0M
PUMP
Column
I. 50 ml/min. NHaHzP04
DH 2.50, 5.10-3M
Waste
!.60
1.20
ml/min.
Buffer solution (pH 7)
2.50
Spectrofluori meter Recorder
Figure 1.
XEXC" 501nm
XEMI :358nm
Chromatographic and analytical system for automated determination of 5-HIAA.
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Figur 2. Ctwootogms ofHn (1), rine+2#tool (2)ie+ 50 #mol/l 5-HIAA (?), od 25 #ol/15-HIAA
standard (4).
A, B and C=height of peaks corresponding to 5-HIAA; a, b, c=height of peaks corresponding to NAT? 5-HT=5-hydroxytryptamine; 5-HTP=5-
hydroxytryptophan; Trp tryptophan.
The fluorometric spectrum for 5-HIAA was verified with our
apparatus and maximal excitation and emission wavelengths
were found to be 301 and 338nm respectively. Fluorometric pH
readings for 5-HIAA were studied between 2 and 10, and the
optimal pH was 7"0 (at this pH the fluorescence intensity of 5-
HIAA increased fourfold compared to that at pH 2"30).
Chromatography requires the use ofan internal standard to
eliminate uncertainty regarding the volumes injected. The
spectrofluorometric characteristics of NAT enable satisfactory
detection under the conditions described above. Its retention
time is min. 30 longer than that of 5-HIAA.
Fluorometric detection requires standardization by over-
loading. The overloading yield (R) was established for each
determination. It enabled us to determine the presence of either
a fluorescence activator (R > 100%) or inhibitor (R < 100%). In
99 of cases the overload yield was between 90 and 105.
Minor interferences were then automatically corrected by
calculating the overload.
Analytical results
The authors found a detection limit of pmol which agreed with
the results in the literature [6, 7, 8].
Linearity was satisfactory up to 250 gmol/1, i.e. about 10
times the usual mean value.
As regards within-run precision, 36 successive measurements
of the same sample (28.5#mol/1) showed the following co-
efficients of variation (CV): 2.90 for manual injection, 1.30
for automatic injection with no internal standard, and 0.72 for
automatic injection with an internal standard.
Sample preparation is simple and quick (a few minutes) and
one sample can be injected every 7 rain. Since injection is
automatic, the apparatus requires no supervision.
The absence of contamination was verified by measuring
alternately low standards (5/tmol/1) and high standards
(100/mol/1). There was no significant difference (p<0"05) be-
tween the low standard values, whether they preceded or
followed the high values.
The specificity of 5-HIAA determinations was ensured by
combining chromatographic separation and spectrofluoromet-
ric detection, as follows:
(1) Chromatography permitted separation of5-HIAA from
its metabolic precursors present in urine.
(2) Spectrofluorometry was carried out at maximum wave-
lengths and at the optimum pH for 5-HIAA.
Absence of interference was tested on certain drugs, par-
ticularly those interfering in the e-nitrosonaphtol technique. For
each test, the drug was added to urine at a concentration
corresponding to the maximum therapeutic dose: 6 g/1 acetyl-
salicyclic acid, 150mg/1 of promethazine, 200mg/1 chlortetra-
cycline, 2"5 g/l sulfamethoxazole, 150rag/1 chlorpromazine and
100mg/1 prochlorperazine. At these concentrations, unlike the
colorimetric method, no significant interference was shown.
Comparison of the direct method suggested was tested with
(a) the same method but preceded by ethyl acetate extraction; (b)
with a spectrofluorometric reference method.
(a) Ethyl acetate extraction
This technique is long but has great specificity, since 5-HIAA is
the only metabolite extracted from urine in large amounts, see
figures 3 (a) and (b). The extraction yield was 94 +_5 (N-54).
A schematic indication of the procedure adopted is given in
table 2. 50 #1 samples were injected into the chromatograph
under the conditions specified above. Comparison with the
direct method (without extraction) gave the following results"
correlation line: y-0.97 x+0.09; correlation coefficient"
r=0"992 (N-54). These results indicate that chromatographic
separation specificity is sufficient in most cases and does not
require prior extraction.
(b) Spectrofluorometric reference method
68 determinations of urinary 5-HIAA were compared using
a manual spectrofluorometric technique. The technique was
preceded by extraction [3]. Statistical study showed a
good correlation: correlation line’ y=0.89 x+ 1"88; correlation
coefficient’ r=0’96; (Student)- 38"9 > theoretical t-3.44
(p< 0"001). Reference values, determined in 112 healthy subjects,
were 25+ 20 #mol/24 h (m+ 2r, p< 0"05). These values agree
with those found by several authors, see references [1-5] and
[11-14].
Urinary 5-HIAA was also determined in 19 cases with
carcinoid tumours. Values ranged from 94 to 4350/mol/24 h. A
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Figure 3 (a and b). Chromatograms ofethyl acetate extract (A), aqueous phase extract (B), and 1 #l ofcarcinoid urine (C).
Table 2. Procedure adopted for the ethylacetate extrac-
tion method.
External
standard
5-HIAA U
25 #mol/1
U+ U+
25 #mol/l 50 #mol/1
In 5 ml glass tubes
NaC1 100mg 100mg 100mg 100mg
HC1 6N 20 #1 20 #1 20 #1 20 #1
Acidified urine 0 500 #1 500 #1 500 #1
HC1 0’01 N 550 #1 100 #1 50 #1
5-HIAA 250 #mol/1 50 #1 50 #1 100 #1
Ethyl acetate 1000 #1 1000 #1 1000 #1 1000 #1
Stopper the tubes, vortex-stir for 3 min.; centrifuge when necessary,
remove the organic phase and treat as follows:
Organic phase 500 #1 500 #1 500 #1 500#1
Evaporate to dryness in waterbath at 31C with a vacuum pump and
resuspend the residue
Mobile phase 500 #1 500 #1 500 #l 500#1
NAT 2 mmol/1 100 #1 100 #l 100 #1 100 #1
chromatogram of carcinoid tumour urine is shown in figure 2.
Results were excellently correlated with the reference technique
[3-1 and agreed with clinical and anatomopathological
observations.
Conclusion
High performance liquid chromatography, combined with
continuous-flow fluorometric detection at an optimized pH,
permits quick specific measurements of urinary 5-HIAA. Since
the method is both completely automated and simple, it can be
used for systematic determinations in carcinoid tumour detec-
tion. Its specificity enables ethyl acetate extraction to be avoided
and its precision and sensitivity make it a particularly reliable
method for use in clinical biochemical laboratories.
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